Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Retained Earnings (2016 - 2025)

Ptc Therapeutics has reported Retained Earnings over the past 14 years, most recently at $10.5 million for Q4 2025.

  • Quarterly results put Retained Earnings at $10.5 million for Q4 2025, up 100.29% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (up 100.29% YoY), and the annual figure for FY2025 was $10.5 million, up 100.29%.
  • Retained Earnings for Q4 2025 was $10.5 million at Ptc Therapeutics, up from -$2.8 billion in the prior quarter.
  • Over the last five years, Retained Earnings for PTCT hit a ceiling of $10.5 million in Q4 2025 and a floor of -$3.6 billion in Q4 2024.
  • Median Retained Earnings over the past 5 years was -$28.6 million (2021), compared with a mean of -$1.2 billion.
  • Biggest five-year swings in Retained Earnings: crashed 283703.35% in 2024 and later skyrocketed 144.59% in 2025.
  • Ptc Therapeutics' Retained Earnings stood at -$24.3 million in 2021, then tumbled by 10842.15% to -$2.7 billion in 2022, then surged by 99.95% to -$1.3 million in 2023, then crashed by 283703.35% to -$3.6 billion in 2024, then soared by 100.29% to $10.5 million in 2025.
  • The last three reported values for Retained Earnings were $10.5 million (Q4 2025), -$2.8 billion (Q3 2025), and $7.4 million (Q2 2025) per Business Quant data.